SECURITIES AND EXCHANGE COMMISSION
 
Washington, D.C. 20549
 
 
FORM 6-K
 
 
REPORT OF FOREIGN PRIVATE ISSUER
 
 
Pursuant to Rule 13a-16 or 15d-16 of

the Securities Exchange Act of 1934



For the month of October, 2015


AVIVA PLC



(Translation of registrant's name into English)


ST HELEN’S, 1 UNDERSHAFT
LONDON EC3P 3DQ

(Address of principal executive offices)



 
Indicate by check mark whether the registrant files or will file annual reports
under cover Form 20-F or Form 40-F.

 
 
Form 20-F X     Form 40-F


 
 
Indicate by check mark whether the registrant by furnishing the information
contained in this Form is also thereby furnishing the information to the
Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.



 
Yes      No X


 
 
If "Yes" is marked, indicate below the file number assigned to the registrant
in connection with Rule 12g3-2(b): 82-



 

 


 

News Release
 
Aviva plc
Interim management statement to 30 September 2015
29 October 2015
 
Aviva plc Third Quarter 2015
Interim Management Statement
Mark Wilson, Group Chief Executive Officer, said:
 
"We are maintaining the momentum of Aviva's transformation with a further quarter of improved performance. In life insurance, value of new business was up 25%¹, the eleventh consecutive quarter of growth. The general insurance combined ratio of 94.0% is a more than adequate result. This level of consistency is important as we transform and grow Aviva.
 
"The acquisition of Friends Life is everything we expected it to be. We have now achieved £91 million of savings against our target of £225 million. At the same time our UK Life business continues to grow and our customers are responding positively to the full range of pensions freedoms we offer.
 
"In asset management, our flagship fund range, AIMS, continues its strong investment performance and the Target Return Fund has recorded returns of 6.6% over the past 12 months. AIMS now has £1.9 billion of funds under management. We expect this growth to continue."
 
9M15 numbers include Friends Life from 10 April 2015, the acquisition completion date. 9M14 is Aviva standalone.
 
Life Insurance
· Value of new business² (VNB) grew 25%¹ to £823 million (9M14: £685 million)
 
· UK Life VNB grew 36% to £404 million (9M14: £297 million), up 13% excluding Friends Life
 
· Aviva platforms continue to grow with over £2.2 billion of net inflows in the nine months to 30th September 2015 taking AUM to £7.3 billion
 
· Europe2 VNB grew 11%1 to £284 million with particularly strong growth in Italy2 up 55%1 to £57 million. Asia2 VNB up 21%1 to £115 million (9M14: £92 million)
 
General Insurance
· Combined operating ratio (COR) improved to 94.0% (9M14: 95.9%)
 
· UK & Ireland COR of 92.8% (9M14: 94.2%), Canada COR of 94.2% (9M14: 96.8%), Europe COR of 97.1% (9M14: 99.8%)
 
· GI and health net written premiums up 2%1 to £6,110 million
 
1Asset Management
· AIMS Target Return fund continues to outperform peers with a return of 6.6% over the past 12 months. The AIMS suite of funds now has £1.9 billion under management.
 
1Balance sheet
· IFRS net asset value up 2% to 387p per share (HY15: 380p)
 
· Resilient capital position throughout recent market volatility with an economic capital surplus3 of £10.1 billion (HY15: £10.8 billion), a coverage ratio of 172% (HY15: 176%) performing in line with our published sensitivities
 
· S&P revised upwards the financial risk profile of the Group to strong and S&P leverage ratio remains stable at 27% (HY15: 27%4)
 
1Friends Life integration
· £91 million of run-rate synergies achieved against a £225 million target - ahead of plan
 
· £23 billion of Friends Life assets due to be transferred from AXA Investment Managers in November
 
 
1 On a constant currency basis.
2 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
3 The economic capital surplus represents an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital as required by regulators or other third parties.
4 HY15 S&P leverage ratio is on a pro-forma basis, taking account of planned redemptions, calls and other reductions of debt in Q3 2015.
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
Page 2
 
 
Key financial metrics
 
Operating capital generation 
 
 
9 months 2015
£bn
9 months 2014
£bn
United Kingdom & Ireland Life
0.7
0.5
United Kingdom & Ireland General Insurance & Health
0.3
0.3
Europe
0.3
0.4
Canada
0.1
0.1
Asia and Other
-
-
Total
1.4
1.3
 
Value of new business
 
 
9 months 2015
£m
9 months 2014
£m
Sterling % change1
Constant currency % change1
United Kingdom & Ireland
415
303
37%
38%
France
144
156
(8)%
2%
Poland2
46
46
-
11%
Italy2
57
41
39%
55%
Spain2
20
19
3%
15%
Turkey
17
23
(25)%
(15)%
Asia2
115
92
24%
21%
Aviva Investors
9
5
72%
72%
Value of new business2
823
685
20%
25%
 
General insurance combined operating ratio
 
 
9 months 2015
9 months 2014
Change
United Kingdom & Ireland3
92.8%
94.2%
(1.4)pp
Europe
97.1%
99.8%
(2.7)pp
Canada
94.2%
96.8%
(2.6)pp
General insurance combined operating ratio
94.0%
95.9%
(1.9)pp
 
Capital position
 
 
30 September 2015
£bn
30 June
2015
£bn
Sterling% change
Estimated economic capital surplus4
10.1
10.8
(6)%
Estimated IGD solvency surplus4
5.2
5.2
-
IFRS net asset value per share
387p
380p
2%
MCEV net asset value per share5
504p
508p
(1)%
 
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
3 Excludes the one-off impact from an outward quota share reinsurance agreement completed in 2015 in Aviva Insurance Limited (AIL).
4 The economic capital and IGD surpluses represent an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital as required by regulators or other third parties.
5 In preparing the MCEV information, the directors have done so in accordance with the European Insurance CFO Forum MCEV Principles.
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
Page 3
 
 
Chief Executive Officer's report
 
Overview
We are maintaining the momentum of Aviva's transformation. Value of new business is up 25%¹ to £823 million (9M14: £685 million2), the combined operating ratio has improved to 94.0% (9M14: 95.9%) and run-rate synergies from the Friends Life acquisition have grown to £91 million (HY15: £63 million).
 
Our economic capital has remained resilient at 172% despite significant market volatility in the third quarter, with our capital sensitivities proving accurate. We expect a positive outcome to our Solvency II internal model application, due to be announced in December this year. We have completed two projects to further improve our balance sheet, reinsuring the majority of our UK general insurance latent risk portfolio in September and disposing of a £2.2 billion portfolio of non-core commercial mortgages in October.
 
Work continues to transform Aviva into a leading digital insurer and we will open our second Digital Garage in Singapore in December. We are seeing encouraging growth in the volume of customer interactions that are completed online, albeit from a low base. We continue to develop our suite of digital propositions to be implemented across our business units.
 
Life Insurance
 
· Value of new business up 25% in constant currency
· UK Life up 36%
Value of new business, our growth measure for life insurance, increased 25% in constant currency to £823 million (9M14: £685 million2).
 
VNB in the UK grew 36% to £404 million. Excluding Friends Life, UK VNB was 13% higher at £335 million, principally reflecting improved performance in pensions. All UK Life customers are now able to benefit from the full range of pensions freedoms on our consumer platform. Total assets on our platforms now stand at £7.3 billion with 25% of platform net flows being invested with Aviva Investors. Ireland Life VNB grew 110%1 to £11 million as a result of higher margins in pensions and savings products.
 
In our developed European markets, France VNB grew 2%1 to £144 million principally due to higher sales and improved margin on protection products, partly offset by lower margins on savings products as a result of lower risk free rates. Italy2 continued its strong turnaround, with 55%1 growth in VNB to £57 million (9M14: £41 million), reflecting improved margins on savings and protection products, while in Spain2 VNB grew by a creditable 15%1.
 
Performance in our growth markets remained positive with attractive underlying trends. These businesses account for 22% of our Group VNB and we will look to allocate more capital to these areas. Poland2 VNB was 11%1 higher at £46 million despite the non recurrence of an £8 million benefit to VNB in 2014 from pension regulatory change. In Turkey, VNB fell 15%1 to £17 million (9M14: £23 million) as the impact of underlying growth was offset by a reduction in our share of the business following the partial IPO. Asia2 grew 21%1 as strong performances in China and Singapore were partly offset by India.
 
Friends Life Integration
At the end of the third quarter we have secured run-rate synergies of £91 million, an increase of £28 million from the half year against a £225 million target. The transfer of £23 billion of Friends Life assets from AXA Investment Managers is due to occur in November. Overall capital synergies from the acquisition are expected to be material. The integration is progressing well and ahead of our internal timetable.
 
The acquisition of Friends Life has created the largest life insurer in the UK. As a result we are in a strong position to look after our customers' entire savings, pensions and retirement needs. For example, we offer the full range of pension freedoms; we are the number one corporate pension provider and have recently launched our new combined Group protection proposition.
 
 
1 On a constant currency basis.
2 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG and Asia excludes South Korea.
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
Page 4
 
 
Group Chief Executive Officer's report continued
 
General Insurance
 
·COR improved 1.9pp to 94.0%
· GI and health net written premiums 2% higher in constant currency
Our general insurance combined operating ratio (COR) improved 1.9 percentage points to 94.0% (9M14: 95.9%) due to lower weather losses and improved efficiency. General insurance and health net written premiums were 2% higher in constant currency at £6,110 million.
 
The UK & Ireland COR improved 1.4 percentage points to 92.8% (9M14: 94.2%), with growth in net written premiums continuing with a 1%¹ improvement. We continue to reshape our distribution and portfolio mix, exiting unprofitable lines of business and reallocating capital to our Digital & True Customer Composite propositions. Further to our announcement at the half year of our new distribution agreement with TSB, we are announcing today a new exclusive five year agreement to underwrite home assistance products for HomeServe's 2 million UK customers.
 
In Canada, the COR improved 2.6 percentage points to 94.2% (9M14: 96.8%) reflecting better overall weather experience, offset mainly by large loss experience in personal property. Net written premiums are 2%1 higher despite selected exits from unprofitable business lines.
 
The European COR improved to 97.1% (9M14: 97.7%2) through a combination of better weather in France and a lower expense ratio across all markets. General insurance and health net written premiums grew 3%2 to £1,067 million on a constant currency basis.
 
Asset Management
 
·AIMS now has £1.9 billion of FUM
Aviva Investors continues to make progress on its turnaround during a period of difficult industry conditions. Gross sales of £4.0 billion are encouraging and are at a higher margin than redemptions, which remain too high at £4.5 billion.
 
The AIMS flagship range of funds continues its strong performance versus peers and now has £1.9 billion of funds under management. During the third quarter, performance has been broadly flat versus the FTSE 100 which has dropped 6%, and over the past 12 months the Target Return Fund has outperformed peers and recorded returns of 6.6%. Our partnership with Virtus Investment Partners in the United States launched successfully and we continue to seek more international distribution agreements.
 

Balance sheet
· Economic capital surplus3 £10.1 billion
Aviva's balance sheet remains strong with a 3Q15 economic capital surplus3 of £10.1 billion (HY15: £10.8 billion). Our coverage ratio of 172% has been resilient during the volatile investment markets seen in the third quarter and has performed as expected and in line with published sensitivities.
 
Our IFRS book value per share increased 2% over the quarter to 387p per share (HY15: 380p). Operating profits and a small increase in our pension surplus more than offset the negative impact of investment variances.
 
During the quarter, we completed a reinsurance transaction that includes provision of c.£0.8 billion of adverse development cover for our UK General Insurance latent reserves. This provides significant protection against claims volatility from mesothelioma, industrial deafness and other long tail risks. The transaction produces an economic capital benefit of c.£0.1 billion and will lead to a one-off IFRS loss before tax of c.£56 million. There will be an on-going reduction in investment income, estimated at c.£10 million per annum, as a result of transferring assets to settle the reinsurance premium.
 
In UK Life, we disposed of £2.2 billion of non-core commercial mortgages in October.
 
Solvency II
We expect to obtain approval for our internal model in December 2015 and whilst we are in the process of finalising the remaining issues, we are comfortable with our level of capital and satisfied that it will be within our expected Solvency II range.
 
We will report our Solvency II numbers for the first time at our full year results in March 2016 and we will also provide our target capital range, sensitivities and roadmap for capital going forward at that time.
1 On a constant currency basis.
2 Excluding the Turkish general insurance business disposed of in December 2014.
3 The economic capital surplus represents an estimated position. The economic capital requirement is based on Aviva's own internal assessment and capital management policies. The term 'economic capital' does not imply capital as required by regulators or other third parties.
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
Page 5
 
 
Group Chief Executive Officer's report continued
 
Digital
Digital remains crucial to our future success and our position as a True Customer Composite gives us a strategic advantage. Our second digital garage will be opened in Singapore in December. Good progress has been made in hiring our global digital leadership team, bringing industry leading expertise in digital design and digital marketing. We are seeing encouraging growth in the volume of customer interactions that are completed online, and continue to develop our suite of digital propositions to be implemented across our business units.
 
Outlook
Our near term priorities are clear; we are focused on delivering the benefits from the Friends Life integration and the transition to Solvency II. Beyond that, there exists significant upside from better capital allocation and a more effective digital customer proposition.
The third quarter results are further evidence of our progress since we started our turnaround. We remain focused on showing improvement in our key metrics year after year.
 
 
 
Mark Wilson
Group Chief Executive Officer
 
_____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
 
Page 6
 
 
Notes to editors
All comparators are for the 9 months to 30 September 2014 unless otherwise stated.
Income and expenses of foreign entities are translated at average exchange rates while their assets and liabilities are translated at the closing rates on 30 September 2015. The average rates employed in this announcement are 1 euro = £0.73 (9 months to 30 September 2014: 1 euro = £0.81) and CAD$1 = £0.52 (9 months to 30 September 2014: CAD$1 = £0.55).
Growth rates in the press release have been provided in sterling terms unless stated otherwise. The following supplement presents this information on both a sterling and constant currency basis.
 
Cautionary statements:
This should be read in conjunction with the documents filed by Aviva plc (the "Company" or "Aviva") with the United States Securities and Exchange Commission ("SEC"). This announcement contains, and we may make other verbal or written "forward-looking statements" with respect to certain of Aviva's plans and current goals and expectations relating to future financial condition, performance, results, strategic initiatives and objectives. Statements containing the words "believes", "intends", "expects", "projects", "plans", "will," "seeks", "aims", "may", "could", "outlook", "likely", "target", "goal", "guidance", "trends", "future", "estimates", "potential" and "anticipates", and words of similar meaning, are forward-looking. By their nature, all forward-looking statements involve risk and uncertainty. Accordingly, there are or will be important factors that could cause actual results to differ materially from those indicated in these statements. Aviva believes factors that could cause actual results to differ materially from those indicated in forward-looking statements in the announcement include, but are not limited to: the impact of ongoing difficult conditions in the global financial markets and the economy generally; the impact of simplifying our operating structure and activities; the impact of various local political, regulatory and economic conditions; market developments and government actions regarding the sovereign debt crisis in Europe; the effect of credit spread volatility on the net unrealised value of the investment portfolio; the effect of losses due to defaults by counterparties, including potential sovereign debt defaults or restructurings, on the value of our investments; changes in interest rates that may cause policyholders to surrender their contracts, reduce the value of our portfolio and impact our asset and liability matching; the impact of changes in short or long term inflation; the impact of changes in equity or property prices on our investment portfolio; fluctuations in currency exchange rates; the effect of market fluctuations on the value of options and guarantees embedded in some of our life insurance products and the value of the assets backing their reserves; the amount of allowances and impairments taken on our investments; the effect of adverse capital and credit market conditions on our ability to meet liquidity needs and our access to capital; changes in, or restrictions on, our ability to initiate capital management initiatives or an acceleration of repayment of intercompany indebtedness; changes in or inaccuracy of assumptions in pricing and reserving for insurance business (particularly with regard to mortality and morbidity trends, lapse rates and policy renewal rates), longevity and endowments; a cyclical downturn of the insurance industry; the impact of natural and man-made catastrophic events on our business activities and results of operations; our reliance on information and technology and third-party service providers for our operations and systems; the inability of reinsurers to meet obligations or unavailability of reinsurance coverage; increased competition in the UK and in other countries where we have significant operations; the effect of the European Union's "Solvency II" rules on our regulatory capital requirements; the impact of actual experience differing from estimates used in valuing and amortising deferred acquisition costs ("DAC") and acquired value of in-force business ("AVIF"); the impact of recognising an impairment of our goodwill or intangibles with indefinite lives; changes in valuation methodologies, estimates and assumptions used in the valuation of investment securities; the effect of legal proceedings and regulatory investigations; the impact of operational risks, including inadequate or failed internal and external processes, systems and human error or from external events; risks associated with arrangements with third parties, including joint ventures; our reliance on third-party distribution channels to deliver our products; funding risks associated with our participation in defined benefit staff pension schemes; the failure to attract or retain the necessary key personnel; the effect of systems errors or regulatory changes on the calculation of unit prices or deduction of charges for our unit-linked products that may require retrospective compensation to our customers; the effect of fluctuations in share price as a result of general market conditions or otherwise; the effect of simplifying our operating structure and activities; the effect of a decline in any of our ratings by rating agencies on our standing among customers, broker-dealers, agents, wholesalers and other distributors of our products and services; changes to our brand and reputation; changes in government regulations or tax laws in jurisdictions where we conduct business, including decreased demand for annuities in the UK due to changes in UK law; the inability to protect our intellectual property; the effect of undisclosed liabilities, integration issues and other risks associated with our acquisitions; and the timing/regulatory approval impact, integration risk and other uncertainties, such as non-realisation of expected benefits or diversion of management attention and other resources, relating to announced acquisitions and pending disposals and relating to future acquisitions, combinations or disposals within relevant industries, including specifically the acquisition of Friends Life; the policies, decisions and actions of government or regulatory authorities in the UK, the EU, the US or elsewhere, including the implementation of key legislation and regulation. For a more detailed description of these risks, uncertainties and other factors, please see Item 3d, "Risk Factors", and Item 5, "Operating and Financial Review and Prospects" in Aviva's most recent Annual Report on Form 20-F as filed with the SEC on 16 March 2015 and also the risk factors contained in the Euro Note Programme prospectus published on 1 May 2015. Aviva undertakes no obligation to update the forward looking statements in this announcement or any other forward-looking statements we may make. Forward-looking statements in this presentation are current only as of the date on which such statements are made.
 
Aviva plc is a company registered in England No. 2468686.
Registered office
St Helen's
1 Undershaft
London
EC3P 3DQ
 
 
 
 
Contacts
 
Investor contacts
Media contacts
Timings
Colin Simpson
+44 (0)20 7662 8115
 
David Elliot
+44 (0)20 7662 8048
Nigel Prideaux
+44 (0)20 7662 0215
 
Andrew Reid
+44 (0)20 7662 3131
 
Sarah Swailes
+44 (0)20 7662 6700
Real time media conference call: 07.30 hrs GMT
 
Analyst conference call: 08.30 hrs GMT
Tel: +44 (0)20 3367 9433
Conference ID: 511455
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
Page 7
 
 
Statistical supplement
 
1. Basis of preparation
 
2. Trend analysis of VNB - cumulative
 
3. Trend analysis of VNB - discrete
 
4. Trend analysis of PVNBP - cumulative
 
5. Trend analysis of PVNBP - discrete
 
6. Trend analysis of PVNBP by product - cumulative
 
7. Trend analysis of PVNBP by product - discrete
 
8. Geographical analysis of regular and single premiums
 
9. Trend analysis of Investment sales - cumulative
 
10. Trend analysis of Investment sales - discrete
 
11. Geographical analysis of regular and single premiums - investment sales
 
12. Trend analysis of general insurance and health net written premiums - cumulative
 
13. Trend analysis of general insurance and health net written premiums - discrete
 
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
Page 8
 
 
1 - Basis of preparation
 
The information included in this announcement and statistical supplement includes the results of Friends Life from 10 April 2015, the acquisition completion date. For the avoidance of doubt, all results for periods prior to 2Q15 are Aviva standalone.
 
2 - Trend analysis of VNB - cumulative
 
                 
Growth1 on 3Q14
Gross of tax and non-controlling interests
1Q14 YTD
£m
2Q14 YTD
£m
3Q14 YTD £m
4Q14 YTD £m
1Q15 YTD £m
2Q15 YTD £m
3Q15 YTD £m
Sterling
%
Constant currency %
United Kingdom2
89
177
297
473
103
253
404
36%
36%
Ireland
3
6
6
9
3
7
11
89%
110%
United Kingdom & Ireland
92
183
303
482
106
260
415
37%
38%
France
54
110
156
205
56
98
144
(8)%
2%
Poland3
21
34
46
64
15
30
46
-
11%
Italy - excluding Eurovita
15
26
41
63
19
39
57
39%
55%
Spain - excluding CxG
6
14
19
30
6
13
20
3%
15%
Turkey4
6
14
23
30
6
12
17
(25)%
(15)%
Europe
102
198
285
392
102
192
284
(1)%
11%
Asia5 - excluding South Korea
29
61
92
122
36
76
115
24%
21%
Aviva Investors6
-
2
5
9
3
6
9
72%
72%
Value of new business - excluding Eurovita, CxG & South Korea
223
444
685
1,005
247
534
823
20%
25%
Eurovita, CxG & South Korea
1
-
1
4
-
-
-
-
-
Total value of new business
224
444
686
1,009
247
534
823
20%
25%
 
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 United Kingdom includes Friends UK from 10 April 2015.
3 Poland includes Lithuania.
4 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
5 Asia includes FPI from 10 April 2015.
6 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
 
3 - Trend analysis of VNB - discrete
 
                 
Growth1 on 3Q14
Gross of tax and non-controlling interests
1Q14 Discrete
£m
2Q14 Discrete
£m
3Q14 Discrete
£m
4Q14 Discrete
£m
1Q15 Discrete
£m
2Q15 Discrete
£m
3Q15 Discrete
£m
Sterling
%
Constant currency
%
United Kingdom2
89
88
120
176
103
150
151
26%
26%
Ireland
3
3
-
3
3
4
4
-
-
United Kingdom & Ireland
92
91
120
179
106
154
155
31%
30%
France
54
56
46
49
56
42
46
-
9%
Poland3
21
13
12
18
15
15
16
33%
43%
Italy - excluding Eurovita
15
11
15
22
19
20
18
22%
34%
Spain - excluding CxG
6
8
5
11
6
7
7
47%
60%
Turkey4
6
8
9
7
6
6
5
(42)%
(35)%
Europe
102
96
87
107
102
90
92
7%
17%
Asia5 - excluding South Korea
29
32
31
30
36
40
39
25%
23%
Aviva Investors6
-
2
3
4
3
3
3
(17)%
(17)%
Value of new business - excluding Eurovita, CxG & South Korea
223
221
241
320
247
287
289
20%
24%
Eurovita, CxG & South Korea
1
(1)
1
3
-
-
-
-
-
Total value of new business
224
220
242
323
247
287
289
19%
23%
 
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 United Kingdom includes Friends UK from 10 April 2015.
3 Poland includes Lithuania.
4 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
5 Asia includes FPI from 10 April 2015.
6 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
 
Page 9
 
 
4 - Trend analysis of PVNBP - cumulative
 
                 
Growth2 on 3Q14
Present value of new business premiums1
1Q14 YTD £m
2Q14 YTD £m
3Q14 YTD £m
4Q14 YTD £m
1Q15 YTD £m
2Q15 YTD £m
3Q15 YTD £m
Sterling
%
Constant currency %
United Kingdom3,8
2,931
6,052
9,098
12,009
2,445
7,071
11,696
29%
29%
Ireland
105
196
291
435
132
270
406
39%
55%
United Kingdom & Ireland
3,036
6,248
9,389
12,444
2,577
7,341
12,102
29%
29%
France
1,310
2,427
3,538
4,633
1,319
2,553
3,639
3%
15%
Poland4
234
332
429
573
110
218
319
(26)%
(18)%
Italy - excluding Eurovita
698
1,440
2,060
2,473
603
1,116
1,518
(26)%
(18)%
Spain - excluding CxG
270
536
743
1,054
224
363
455
(39)%
(32)%
Turkey5
110
231
348
495
134
251
347
-
12%
Europe
2,622
4,966
7,118
9,228
2,390
4,501
6,278
(12)%
(2)%
Asia6 - excluding South Korea
421
867
1,357
1,854
623
1,449
2,218
63%
60%
Aviva Investors7
5
257
562
881
366
761
1,165
107%
107%
Total - excluding Eurovita, CxG & South Korea
6,084
12,338
18,426
24,407
5,956
14,052
21,763
18%
23%
Eurovita, CxG & South Korea
136
292
307
321
-
-
-
-
-
Total
6,220
12,630
18,733
24,728
5,956
14,052
21,763
16%
21%
 
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 United Kingdom includes Friends UK from 10 April 2015.
4 Poland includes Lithuania.
5 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
6 Asia includes FPI from 10 April 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
 
 
5 - Trend analysis of PVNBP - discrete
 
                 
Growth2 on 3Q14
Present value of new business premiums1
1Q14 Discrete £m
2Q14 Discrete £m
3Q14 Discrete £m
4Q14 Discrete £m
1Q15 Discrete £m
2Q15 Discrete £m
3Q15 Discrete £m
Sterling
%
Constant currency %
United Kingdom3,8
2,931
3,121
3,046
2,911
2,445
4,626
4,625
52%
52%
Ireland
105
91
95
144
132
138
136
42%
56%
United Kingdom & Ireland
3,036
3,212
3,141
3,055
2,577
4,764
4,761
52%
52%
France
1,310
1,117
1,111
1,095
1,319
1,234
1,086
(2)%
7%
Poland4
234
98
97
144
110
108
101
4%
11%
Italy - excluding Eurovita
698
742
620
413
603
513
402
(35)%
(29)%
Spain - excluding CxG
270
266
207
311
224
139
92
(56)%
(52)%
Turkey5
110
121
117
147
134
117
96
(18)%
(7)%
Europe
2,622
2,344
2,152
2,110
2,390
2,111
1,777
(17)%
(10)%
Asia6 - excluding South Korea
421
446
490
497
623
826
769
57%
55%
Aviva Investors7
5
252
305
319
366
395
404
33%
33%
Total - excluding Eurovita, CxG & South Korea
6,084
6,254
6,088
5,981
5,956
8,096
7,711
27%
31%
Eurovita, CxG & South Korea
136
156
15
14
-
-
-
-
-
Total
6,220
6,410
6,103
5,995
5,956
8,096
7,711
26%
30%
 
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 United Kingdom includes Friends UK from 10 April 2015.
4 Poland includes Lithuania.
5 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
6 Asia includes FPI from 10 April 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
 
Page 10
 
 
6 - Trend analysis of PVNBP by product - cumulative
 
                 
Growth2 on 3Q14
Present value of new business premiums1
1Q14 YTD £m
2Q14 YTD £m
3Q14 YTD £m
4Q14 YTD £m
1Q15 YTD £m
2Q15 YTD £m
3Q15 YTD £m
Sterling
%
Constant currency %
Pensions
1,328
2,794
4,081
5,803
1,319
3,897
6,085
49%
49%
Annuities8
500
935
1,656
1,948
136
777
2,205
33%
33%
Bonds
45
87
135
174
39
80
109
(19)%
(19)%
Protection
297
568
862
1,103
268
712
1,152
34%
34%
Equity release
117
257
462
696
206
458
584
26%
26%
Other3
644
1,411
1,902
2,285
477
1,147
1,561
(18)%
(18)%
United Kingdom4
2,931
6,052
9,098
12,009
2,445
7,071
11,696
29%
29%
Ireland
105
196
291
435
132
270
406
39%
55%
United Kingdom & Ireland
3,036
6,248
9,389
12,444
2,577
7,341
12,102
29%
29%
Savings
1,232
2,278
3,347
4,368
1,224
2,389
3,423
2%
14%
Protection
78
149
191
265
95
164
216
13%
26%
France
1,310
2,427
3,538
4,633
1,319
2,553
3,639
3%
15%
Pensions
302
465
631
904
192
356
493
(22)%
(13)%
Savings
890
1,819
2,583
3,182
754
1,330
1,767
(32)%
(24)%
Annuities
2
2
3
5
-
1
1
(56)%
(50)%
Protection
118
253
363
504
125
261
378
4%
16%
Poland5, Italy5, Spain5 and Turkey6
1,312
2,539
3,580
4,595
1,071
1,948
2,639
(26)%
(18)%
Europe
2,622
4,966
7,118
9,228
2,390
4,501
6,278
(12)%
(2)%
Asia5
421
867
1,357
1,854
623
1,449
2,218
63%
60%
Aviva Investors7
5
257
562
881
366
761
1,165
107%
107%
Total - excluding Eurovita, CxG & South Korea
6,084
12,338
18,426
24,407
5,956
14,052
21,763
18%
23%
Eurovita, CxG & South Korea
136
292
307
321
-
-
-
-
-
Total
6,220
12,630
18,733
24,728
5,956
14,052
21,763
16%
21%
 
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Other UK business includes UK Retail Fund Management and UK long term health business. UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
4 United Kingdom includes Friends UK from 10 April 2015.
5 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG. Asia includes FPI from 10 April 2015 and excludes South Korea.
6 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
 
 
7 - Trend analysis of PVNBP by product - discrete
 
               
Growth2
on 3Q14
Present value of new business premiums1
1Q14 Discrete £m
2Q14 Discrete £m
3Q14 Discrete £m
4Q14 Discrete £m
1Q15 Discrete £m
2Q15 Discrete £m
3Q15 Discrete £m
Sterling
%
Constant currency %
Pensions
1,328
1,466
1,287
1,722
1,319
2,578
2,188
70%
70%
Annuities8
500
435
721
292
136
641
1,428
98%
98%
Bonds
45
42
48
39
39
41
29
(41)%
(41)%
Protection
297
271
294
241
268
444
440
49%
49%
Equity release
117
140
205
234
206
252
126
(39)%
(39)%
Other3
644
767
491
383
477
670
414
(15)%
(15)%
United Kingdom4
2,931
3,121
3,046
2,911
2,445
4,626
4,625
52%
52%
Ireland
105
91
95
144
132
138
136
42%
56%
United Kingdom & Ireland
3,036
3,212
3,141
3,055
2,577
4,764
4,761
52%
52%
Savings
1,232
1,046
1,069
1,021
1,224
1,165
1,034
(3)%
6%
Protection
78
71
42
74
95
69
52
25%
36%
France
1,310
1,117
1,111
1,095
1,319
1,234
1,086
(2)%
7%
Pensions
302
163
166
273
192
164
137
(17)%
(9)%
Savings
890
929
764
599
754
576
437
(43)%
(38)%
Annuities
2
-
1
2
-
1
-
6%
16%
Protection
118
135
110
141
125
136
117
5%
15%
Poland5, Italy5, Spain5 and Turkey6
1,312
1,227
1,041
1,015
1,071
877
691
(34)%
(27)%
Europe
2,622
2,344
2,152
2,110
2,390
2,111
1,777
(17)%
(10)%
Asia5
421
446
490
497
623
826
769
57%
55%
Aviva Investors7
5
252
305
319
366
395
404
33%
33%
Total - excluding Eurovita, CxG & South Korea
6,084
6,254
6,088
5,981
5,956
8,096
7,711
27%
31%
Eurovita, CxG & South Korea
136
156
15
14
-
-
-
-
-
Total
6,220
6,410
6,103
5,995
5,956
8,096
7,711
26%
30%
 
1 Present value of new business premiums (PVNBP) is the present value of new regular premiums plus 100% of single premiums, calculated using assumptions consistent with those used to determine the value of new business.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Other UK business includes UK Retail Fund Management and UK long term health business. UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
4 United Kingdom includes Friends UK from 10 April 2015.
5 Poland includes Lithuania, Italy excludes Eurovita, Spain excludes CxG. Asia includes FPI from 10 April 2015 and excludes South Korea.
6 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
7 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
8 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
 
Page 11
 
 
 
8 - Geographical analysis of regular and single premiums
 
             
Regular premiums
    
Single premiums
 
9 months 2015
£m
Constant currency growth1
WACF
Present value
£m
9 months 2014
£m
WACF
Present value £m
9 months 2015
£m
9 months 2014
£m
Constant currency growth1
United Kingdom2,7
1,029
39%
6.1
6,236
740
5.0
3,699
5,460
5,399
1%
Ireland
18
3%
6.1
109
19
5.1
97
297
194
71%
United Kingdom & Ireland
1,047
38%
6.1
6,345
759
5.0
3,796
5,757
5,593
3%
France
63
10%
9.0
570
63
8.1
512
3,069
3,026
13%
Poland3
29
(16)%
7.9
228
39
8.8
344
91
85
19%
Italy - excluding Eurovita
9
(71)%
7.3
66
33
5.6
185
1,452
1,875
(14)%
Spain - excluding CxG
23
(4)%
6.1
140
27
5.7
154
315
589
(40)%
Turkey4
72
2%
3.9
280
80
3.8
301
67
47
61%
Europe
196
(10)%
6.6
1,284
242
6.2
1,496
4,994
5,622
(1)%
Asia5 - excluding South Korea
240
41%
6.8
1,621
166
6.5
1,087
597
270
118%
Aviva Investors6
-
-
-
-
-
-
-
1,165
562
107%
Total - excluding Eurovita, CxG & South Korea
1,483
30%
6.2
9,250
1,167
5.5
6,379
12,513
12,047
9%
Eurovita, CxG & South Korea
-
-
-
-
33
3.9
130
-
177
-
Total
1,483
26%
6.2
9,250
1,200
5.4
6,509
12,513
12,224
8%
 
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 United Kingdom includes Friends UK from 10 April 2015.
3 Poland includes Lithuania.
4 The shareholding of Aviva's minority interest in our Turkish joint venture reduced from 49.8% to 41.3% on 13 November 2014 through an initial public offering. Aviva's holding was further reduced to 40.0% on 7 August 2015.
5 Asia includes FPI from 10 April 2015.
6 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014.
7 Includes c.£1 billion PVNBP (net of reinsurance) relating to a longevity insurance transaction completed in 3Q15.
 
 
9 - Trend analysis of Investment sales - cumulative
 
                 
Growth2 on 3Q14
Investment sales1
1Q14 YTD £m
2Q14 YTD £m
3Q14 YTD £m
4Q14 YTD £m
1Q15 YTD £m
2Q15 YTD £m
3Q15 YTD £m
Sterling
%
Constant currency %
United Kingdom & Ireland3
486
1,043
1,405
1,742
271
710
1,041
(26)%
(26)%
Aviva Investors4
730
1,616
2,195
3,089
1,073
2,102
3,475
58%
69%
Asia5
36
75
110
146
41
78
103
(6)%
(7)%
Total investment sales
1,252
2,734
3,710
4,977
1,385
2,890
4,619
25%
29%
 
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Some of UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 2014 Investment sales are included at the same amount in UK Life 2014 PVNBP. 3Q15 YTD investment sales of £1,041 million are equivalent to £1,110 million on a PVNBP basis.
4 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. YTD investment sales of £250 million for 2Q14, £549 million for 3Q14, £864 million for 4Q14, £362 million for 1Q15, £755 million for 2Q15 and £1,156 million for 3Q15 are also included in Aviva Investors' PVNBP at the same level following the extension of MCEV covered business.
5 Some of Asia investment sales are also reported in Asia PVNBP following an extension of MCEV covered business in 2015.
 
 
10 - Trend analysis of Investment sales - discrete
 
                 
Growth2 on 3Q14
Investment sales1
1Q14 Discrete £m
2Q14 Discrete £m
3Q14 Discrete £m
4Q14 Discrete £m
1Q15 Discrete £m
2Q15 Discrete £m
3Q15 Discrete £m
Sterling
%
Constant currency %
United Kingdom & Ireland3
486
557
362
337
271
439
331
(9)%
(9)%
Aviva Investors4
730
886
579
894
1,073
1,029
1,373
137%
142%
Asia5
36
39
35
36
41
37
25
(29)%
(29)%
Total investment sales
1,252
1,482
976
1,267
1,385
1,505
1,729
77%
79%
 
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Some of UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 2014 Investment sales are included at the same amount in UK Life 2014 PVNBP. 1Q15 investment sales of £271 million, 2Q15 investment sales of £439 million and 3Q15 investment sales of £331 million are equivalent to £295 million, £479 million and £336 million respectively on a PVNBP basis.
4 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. Discrete investment sales of £250 million for 2Q14, £299 million for 3Q14, £315 million for 4Q14, £362 million for 1Q15, £393 million for 2Q15 and £401 million for 3Q15 are also included in Aviva Investors' PVNBP at the same level following the extension of MCEV covered business.
5 Some of Asia investment sales are also reported in Asia PVNBP following an extension of MCEV covered business in 2015.
 
 
11 - Geographical analysis of regular and single premiums - investment sales
 
     
Regular
    
Single
PVNBP
Investment sales1
9 months 2015
£m
9 months 2014
£m
Constant currency growth2
9 months 2015
£m
9 months 2014
£m
Constant currency growth2
Constant currency growth2
United Kingdom & Ireland3
18
19
(4)%
1,023
1,386
(26)%
(26)%
Aviva Investors4
4
4
4%
3,471
2,191
69%
69%
Asia5
-
-
-
103
110
(7)%
(7)%
Total investment sales
22
23
(2)%
4,597
3,687
29%
29%
 
1 Investment sales are calculated as new single premiums plus the annualised value of new regular premiums.
2 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
3 Some of UK & Ireland investment sales are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 2014 Investment sales are included at the same amount in UK Life 2014 PVNBP. 3Q15 YTD investment sales of £1,041 million are equivalent to £1,110 million on a PVNBP basis.
4 The UK Retail Fund Management business was transferred from UK Life to Aviva Investors on 9 May 2014. YTD investment sales of £250 million for 2Q14, £549 million for 3Q14, £864 million for 4Q14, £362 million for 1Q15, £755 million for 2Q15 and £1,156 million for 3Q15 are also included in Aviva Investors' PVNBP at the same level following the extension of MCEV covered business.
5 Some of Asia investment sales are also reported in Asia PVNBP following an extension of MCEV covered business in 2015.
 
 
 
____________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________________
 
 
Page 12
 
 
12 - Trend analysis of general insurance and health net written premiums - cumulative
 
                 
Growth1 on 3Q14
 
1Q14 YTD £m
2Q14 YTD £m
3Q14 YTD £m
4Q14 YTD £m
1Q15 YTD £m
2Q15 YTD £m
3Q15 YTD £m
Sterling
%
Constant currency %
General insurance
                  
United Kingdom2
845
1,836
2,742
3,663
855
1,851
2,750
-
-
Ireland
65
136
205
272
63
134
210
3%
14%
United Kingdom & Ireland
910
1,972
2,947
3,935
918
1,985
2,960
-
1%
Europe
440
747
999
1,313
399
674
910
(9)%
1%
Canada
426
1,026
1,584
2,104
409
1,013
1,519
(4)%
2%
Asia & Other
7
12
15
20
3
6
8
(47)%
(47)%
 
1,783
3,757
5,545
7,372
1,729
3,678
5,397
(3)%
1%
Health insurance
                  
United Kingdom3
144
302
394
518
158
315
423
7%
7%
Ireland
33
47
65
93
28
42
58
(10)%
-
United Kingdom & Ireland
177
349
459
611
186
357
481
5%
6%
Europe
94
138
182
243
89
128
157
(14)%
(4)%
Asia4
29
45
61
74
33
55
75
23%
24%
 
300
532
702
928
308
540
713
2%
5%
Total
2,083
4,289
6,247
8,300
2,037
4,218
6,110
(2)%
2%
 
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 Excludes the one-off impact from an outward quota share reinsurance agreement completed in 2015 in Aviva Insurance Limited (AIL).
3 These premiums are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 1Q14 NWP of £144 million, 2Q14 YTD NWP of £302 million, 3Q14 YTD NWP of £394 million, 4Q14 YTD NWP of £518 million, 1Q15 NWP of £158 million, 2Q15 YTD NWP of £315 million and 3Q15 YTD NWP of £423 million are equivalent to £158 million, £368 million, £497 million, £542 million, £182 million, £373 million and £452 million on a PVNBP basis respectively.
4 Singapore long term health business is also reported in Asia PVNBP following the extension of MCEV covered business in 2014. For Singapore long term health business, 1Q14 NWP of £5 million, 2Q14 YTD NWP of £9 million, 3Q14 YTD NWP of £15 million, 4Q14 YTD NWP of £22 million, 1Q15 NWP of £10 million, 2Q15 YTD NWP of £23 million and 3Q15 YTD NWP of £36 million are equivalent to £37 million, £87 million, £130 million, £183 million, £48 million, £120 million and £184 million on a PVNBP basis respectively.
 
 
13 - Trend analysis of general insurance and health net written premiums - discrete
 
                 
Growth1 on 3Q14
 
1Q14 Discrete £m
2Q14 Discrete £m
3Q14 Discrete £m
4Q14 Discrete £m
1Q15 Discrete £m
2Q15 Discrete £m
3Q15 Discrete £m
Sterling
%
Constant currency %
General insurance
                  
United Kingdom2
845
991
906
921
855
996
899
(1)%
(1)%
Ireland
65
71
69
67
63
71
76
11%
22%
United Kingdom & Ireland
910
1,062
975
988
918
1,067
975
-
1%
Europe
440
307
252
314
399
275
236
(7)%
1%
Canada
426
600
558
520
409
604
506
(9)%
(3)%
Asia & Other
7
5
3
5
3
3
2
(53)%
(53)%
 
1,783
1,974
1,788
1,827
1,729
1,949
1,719
(4)%
-
Health insurance
                  
United Kingdom3
144
158
92
124
158
157
108
18%
18%
Ireland
33
14
18
28
28
14
16
(11)%
(3)%
United Kingdom & Ireland
177
172
110
152
186
171
124
13%
15%
Europe
94
44
44
61
89
39
29
(33)%
(27)%
Asia4
29
16
16
13
33
22
20
28%
29%
 
300
232
170
226
308
232
173
3%
6%
Total
2,083
2,206
1,958
2,053
2,037
2,181
1,892
(3)%
-
 
1 Currency movements are calculated using unrounded numbers so minor rounding differences may exist.
2 Excludes the one-off impact from an outward quota share reinsurance agreement completed in 2015 in Aviva Insurance Limited (AIL).
3 These premiums are also reported in UK Life PVNBP following the extension of MCEV covered business in 2014. 1Q14 NWP of £144 million, 2Q14 NWP of £158 million, 3Q14 NWP of £92 million, 4Q14 NWP of £124 million, 1Q15 NWP of £158 million, 2Q15 NWP of £157 million and 3Q15 NWP of £108 million are equivalent to £158 million, £210 million, £129 million, £45 million, £182 million, £191 million and £79 million on a PVNBP basis respectively.
4 Singapore long term health business is also reported in Asia PVNBP following the extension of MCEV covered business in 2014. For Singapore long term health business, 1Q14 NWP of £5 million, 2Q14 NWP of £4 million, 3Q14 NWP of £6 million, 4Q14 NWP of £7 million, 1Q15 NWP of £10 million, 2Q15 NWP of £13 million and 3Q15 NWP of £13 million are equivalent to £37 million, £50 million, £43 million, £53 million, £48 million, £72 million and £64 million on a PVNBP basis respectively
 

 
 
 
 
SIGNATURES
 
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.





 
 
Date 29 October, 2015
 
AVIVA PLC
   
 
By: /s/ K.A. Cooper
   
 
K.A. Cooper
 
Group Company Secretary